Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Covid-19 OSHA Complaint, Able Services, 1600 Commerce St, BOULDER, CO, 80301, USA

1 month ago

1600 Commerce Street, Boulder, 80301 Colorado, United States

1. Employees are potentially exposed to health hazards associated with COVID-19. The employer has not effectively implemented procedures, or provided training to address employee exposure to the virus that causes COVID-19. It was reported that employees are conducting janitorial operations and are not using the correctly colored rag to clean the appropriate surface. This can lead to cross contamination, and inadequate sanitizing of surfaces. Contrary to Section 5(a)(1) of the OSH Act. Hazard Locations: FA, FM, FT, WE2, CO8, TT, CO3. CO5, RA7, RA11.

Alleged Hazards: 1, Employees Exposed: 100
Source: Osha.gov | Receipt Date: 2021-08-25

2.0K


Related Reports

6 employees tested positive for Covid-19 at PGE Wilsonville Line Center in Clackamas County. Investigation Start Date: 18-11-2021, with the most recent onset of: 20-11-2021 New Cases of: 6

Source: www.oregon.gov See Less
1.0K


6 employees tested positive for Covid-19 at PPM Technologies in Yamhill County. Investigation Start Date: 09-11-2021, with the most recent onset of: 22-11-2021 New Cases of: 6

Source: www.oregon.gov See Less
1.0K


7 employees tested positive for Covid-19 at Precision Aircraft Solutions in Washington County. Investigation Start Date: 18-11-2021, with the most recent onset of: 12-11-2021 New Cases of: 7

Source: www.oregon.gov See Less
1.0K


11 employees tested positive for Covid-19 at Providence Portland Medical Center in Multnomah County. Investigation Start Date: 04-11-2021, with the most recent onset of: 07-11-2021 New Cases of: 11

Source: www.oregon.gov See Less
940


58 employees tested positive for Covid-19 at Roseburg Forest Products: Riddle Plywood in Douglas County. Investigation Start Date: 24-05-2021, with the most recent onset of: 15-11-2021 New Cases of: 58

Source: www.oregon.gov See Less
32


38 employees tested positive for Covid-19 at Target Distribution Center in Linn County. Investigation Start Date: 21-10-2021, with the most recent onset of: 24-11-2021 New Cases of: 38

Source: www.oregon.gov See Less
1.0K


18 employees tested positive for Covid-19 at The Home Depot in Marion County. Investigation Start Date: 07-10-2021, with the most recent onset of: 17-11-2021 New Cases of: 18

Source: www.oregon.gov See Less
1.0K


About 6 minutes after taking second pfizer dose, I began to sweat, blood pressure dropped, nausea set in and almost lost consciousness a couple of times. A nurse and a doctor stayed with me and offered some water. That didn't help ad after about an hour, I... See More was taken by ambulance to emergency room and treated with fluids and anti-nausea feeds. About 5-6 hours later I began to feel better and went home. | Symptoms: Nausea See Less
3.9K
1 Share


SI
anonymous2659
I hope you are going to be ok. How are you feeling now?
1 Reply 2 days ago
DU
anonymous2660
This sounds like allergic reaction and a terrible thing to post on this forum as it enables the narrative that the vaccine “kills/harms” because a TINY fraction of the population has a severe/bad reaction. Your immune system just sounds weak, the simple fact you were given fluids and fully recovered exemplifies that.
People aren’t even reading everything, they read the first part and “oH gOd aRe yOu OkAy” when CLEARLY you are.
-1 Reply 2 days ago
OF
anonymous2692
Its exactly the right place to post side effects . So others can be aware of possible side effects .
1 Reply 20 hours ago
XJ
anonymous2666
sounds like anxiety
-1 Reply 2 days ago
5L
anonymous2676
What in the actual heck is wrong with the people who are so crazy about these jabs and putting down anyone who has a reaction? I have to believe that they are paid spokespersons or something, like who tells someone their reaction is because they are weak... seriously anonymous2660, people have legitimate reactions and concerns and this is the place to voice them, and yet people like you belittle them, what is that even about?
1 Reply 1 day ago
XY
anonymous2682
I love all the comments saying it’s anxiety. I know many people with Heart conditions that they will have the rest of their lives. These reactions are not normal.
Reply 1 day ago
Had the 2nd AZ vaccine and within 10 minutes I went all dizzy and felt really sick and had the shakes. They offered me some water and told me to stay seated for 20 minutes. After that I was able to leave. The next day all of... See More my bones were aching and I felt dizzy and sick with heart palpitations. Day two now and feeling much better. | Symptoms: Dizziness, Body Ache, Shaking See Less
523


When I took my first and second shots made me extremely tired and I had absolutely no energy, didn't even want to take a bath my legs were extremely weak I mean I felt terrible for more than 2 months. And to top it off September 7... See More .I got Covid and almost died. I couldn't stand up.I didn't eat for a week. Nothing tastes good. It was awful. I didn't have any problems with breathing. I don't think I will do the Booster. I told my doctor and he said it was up to Me ! That Covid is terrible. I m check for Covid once a week. See Less
405


DU
anonymous2661
please look up how vaccines work before saying “I will not get the booster” there is NOTHING worrying or concerning about your reaction, your immune system responded accordingly. If anything, it sounds like you have a weak immune system to begin with.
-1 Reply 2 days ago
LI
Littos06
You need to stop. This is sick,I'm reporting you.
Reply 1 day ago
2T
anonymous2680
No breathing problems, but you almost died?.
Reply 1 day ago
FJ
anonymous2686
Maybe you would have dies without the vaccine?
Reply 1 day ago

Recent Interesting Reports

Livia Global, Inc announced the recall of two lots of its liquid probiotics, LiviaOne Liquid Probiotics & BioLifePet Liquid Probiotics, due to the possibility of contamination by Pseudomonas aeruginosa, a microorganism that can cause life-threatening infection in immunocompromised individuals. These products are distributed nationwide through Amazon, wholesale,... See More and direct sales from the company’s website.

Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals. P. aeruginosa infections are generally limited to hospital settings.

This recall only affects the following products with the Lot# 001005-1 Best by: 04/2023 & LiviaOne Nasal Probiotics with Lot# 010620-1 Best by 08/2023 with the following ship dates:
- LiviaOne Daily Probiotics 2oz – UPC 030915 107112 Ship dates 04/16/2021 – 08/30/2021 (1067 units)
- LiviaOne Daily Probiotics 4oz – UPC 030915 107167 Ship dates - 07/09/2021 – 08/30/2021 (384 units)
- LiviaOne Topical Spray Probiotics 4oz – UPC 030915 107105 Ship dates 07/08/2021 – 07/30/2021 (571 units)
- LiviaOne Nasal Probiotics 1oz – UPC 030915 107198 Ship dates 04/21/2021 – 05/12/2021 (480 units)
- LiviaOne Nasal Probiotics 1 oz - UPC 030915 107198 Ship dates 07/14/2021 – 08/24/2021 (600 units)
- LiviaOne Nasal Probiotics 1 oz – Lot# 010620-1 UPC 030915 107198 Ship dates 10/27/2021 – 11/25/2021 (50 units)
- BioLifePet Probiotics for Cats – UPC 030915 107044 Ship dates 05/05/2021 – 07/26/2021 (128 units)
- BioLifePet Probiotics for Dogs – UPC 030915 107037 Ship dates 05/05/2021 – 08/25/2021 (128 units)

Lot numbers are located on the side of the bottle and on the bottom of the outer container in which the product is sold. No other lots or ship dates or any other LiviaOne products are affected by this recall.

Company name: Liva Global, Inc.
Brand name: LivaOne and BioLifePet
Product recalled: Probiotics
Reason of the recall: Pseudomonas aeruginosa
FDA Recall date: December 01, 2021

Check the full recall details on fda.gov

Source: FDA
See Less
102
2 Shares


Foster City, CA, Gilead Sciences Inc. (Nasdaq: GILD) today announced it is voluntarily recalling two lots of Veklury® (remdesivir 100 mg for injection) to the user level. Gilead Sciences Inc. received a customer complaint, confirmed by the firm’s investigation, of the presence of glass particulates.

Risk Statement:... See More The administration of an injectable product that contains glass particulates may result in local irritation or swelling in response to the foreign material. If the glass particulate reaches the blood vessels it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. To date, Gilead Sciences Inc. has not received any reports of adverse events related to this recall.

Veklury is indicated for the treatment of adults and pediatric patients ≥ 12 years old and weighing ≥40 kg requiring hospitalization for COVID-19. The lyophilized form of Veklury (remdesivir 100 mg for injection) is distributed in single dose clear glass vials in powder form and reconstituted at the site of use.

Veklury lots 2141001-1A and 2141002-1A were distributed nationwide in the United States, beginning October 2021. NDC, lot, expiration date and distribution dates can be found below.

Product Description: Veklury® (remdesivir 100mg for injection)
NDC: 61958-2901-02
Lot #: 2141001-1A - 2141002-1A
Expiration Date: 01/2024 - 01/2024
Distribution date to wholesalers: 10/25/21-10/26/2021 - 10/26/21-11/02/2021

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
101


Nutracap Holdings, LLC of Norcross, Georgia is voluntarily recalling various dietary supplements due to undeclared wheat, milk, soy and/or coconut on the labels. People who have an allergy or severe sensitivity to soy, milk, wheat, or coconut run the risk of serious or life-threatening allergic reaction if... See More they consume products containing soy, milk, wheat, or coconut.

On 11/4/2021 during an FDA inspection the firm was notified that their labels failed to disclose the presence of allergens on some of their products. The recalled products were shipped between June 4, 2020 through October 1, 2021 to distributors and retailers in Alabama, California, Florida, and Texas. There have been no illnesses reported to date.

The affected products are:

Brand: Boba Origin. Product: 100% Whey Protein Isolate. Flavor: Brown Sugar Milk, Tea, Undeclared milk, & soy. Size: 1 gallon plastic jar. Lot No. 2106263. Exp. 07/2023

Brand: Etedream. Product: Etegrow ISO. Flavor: Snicker Doodle, Undeclared milk. Size: 2gallon plastic jar. Lot No. 2106002. Exp. 06/2023


Brand: RAW. Product: Vegan Protein Flavor: Peanut Butter, Undeclared coconut. Size: 1gallon plastic jar. Lot No. 2108070, 2104340, 2102018, 2012304, 2010266, 2010102, 2007037/746, 2005132. Exp. 08/2023, 04/2023, 02/2023, 12/2022, 10/2022, 10/2022, 07/2022, 05/2022

Brand: Steel. Product: Veg-Pro Flavor: Cookies & Crème, Undeclared Wheat. Size: 64 ounce plastic jar. Lot No. 2109390, 2104333, 2011260, 2104007/1041, 2105059, 2011260/994. Exp. 09/2023, 04/2023, 11/2022, 04/2023, 05/2023, 11/2022

Brand: Vital Force. Product: PureISO. Flavor: Milk Chocolate, Cocoa, Undeclared milk. Size: 1gallon plastic jar. Lot. No. 2108191. Exp. 09/2023

Brand: Vital Force. Product: PureISO. Flavor: Creamy Peanut, Butter Vanilla, Undeclared milk. Size: 1gallon plastic jar. Lot No. 2109068. Exp. 09/2023

Lot numbers and expiration dates are found on the bottom of each container.

Retailers and distributors who have received any of these products should check inventory, immediately remove from sale and notify customers who purchased them of the recall.

This recall is being made with the knowledge of the Food and Drug Administration.

Company name: Nutracap Holdings, LLC
Brand name: Etedream, Vital Force, Raw, Boba Origin, Steel
Product recalled: Dietary Supplement Protein Powder
Reason of the recall: Undeclared wheat, milk, soy and/or coconut
FDA Recall date: November 09, 2021

Check the full recall details on fda.gov

Source: FDA
See Less
5


The Procter & Gamble Company (NYSE: PG) is voluntarily recalling all lots with expiry through September 2023 of specific Old Spice and Secret aerosol spray antiperspirants and Old Spice Below Deck aerosol spray products sold in the United States, and listed in the table below, to the... See More consumer level due to the presence of benzene detected.

Risk Statement: Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life-threatening. Based on exposure modeling and the cancer risk assessments published by the Environmental Protection Agency (EPA) (IRIS database), daily exposure to benzene in the recalled products at the levels detected in our testing would not be expected to cause adverse health consequences. Benzene is ubiquitous in the environment. Humans around the world have daily exposures to it indoors and outdoors from multiple sources. To date, The Procter & Gamble Company has not received any reports of adverse events related to this recall and is conducting this recall out of an abundance of caution.

The affected products are used as antiperspirants and hygiene products and are packaged in aerosol cans. See the link below for Product names and UPC codes and images for further descriptions. They are recalling all lots with expiry through September 2023 of the products listed in the link below.

Company name: The Proctor & Gamble Company
Brand name: Old Spice Secret
Product recalled: Old Spice and Secret Aerosol Sprays
Reason of the recall: Due to the presence of benzene
FDA Recall date: November 23, 2021

Check the full recall details on fda.gov

Source: FDA
See Less
101


FOR IMMEDIATE RELEASE –07 December 2021 – Buena, NJ, Teligent Pharma, Inc. is voluntarily recalling two lots of Lidocaine HCl Topical Solution USP 4%, 50ml in a screw cap glass bottle listed below to the user level. The product is being recalled because the firms testing has... See More found it to be super potent based on an Out of Specification (OOS) result obtained at the 9-month (Lot 16345) and 18-month (Lot 15594) stability timepoint.

Risk Statement: Use of the super potent product would result in a higher than intended lidocaine dose above that intended. An increased lidocaine dose could lead to the development of local anesthetic systemic toxicity depending on the duration of the treatment and the specific patient. Local anesthetic systemic toxicity can result in central nervous system reactions including excitation and/or depression and more serious signs of cardiovascular toxicity, such as bradycardia, hypotension, and even cardiovascular collapse can present very quickly. If local anesthetic systemic toxicity is not recognized and treated quickly, severe morbidity and even death can result. Adults and the elderly who are more likely to use this product as well as children of lower body weight are more likely to experience local anesthetic systemic toxicity if a higher than intended lidocaine concentration is administered. To date, Teligent Pharma, Inc. has not received any reports of adverse events related to this recall.

Product: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50mL bottle
NDC: 63739-997-64
Lot Number: 15594
Expiration: 05/2023

Product: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50mL bottle
NDC: 63739-997-64
Lot Number: 16345
Expiration: 01/2024

The product is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract and is packaged in a 50ml glass bottle with a screw cap with the identification NDC 63739-997-64. The product can be identified by the following labeling: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL). Product was distributed at the wholesale and retail distribution levels nationwide in the US.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Company name: Teligent Pharma, Inc.
Brand name: Teligent Pharma, Inc.
Product recalled: Lidocaine HCl Topical Solution USP 4%, 50ml
Reason of the recall: Super potent
FDA Recall date: December 07, 2021

Check the full recall details on fda.gov

Source: FDA
See Less
101


FOR IMMEDIATE RELEASE – December 1, 2021 – Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion of lot SAB06761A experienced a temperature excursion during... See More shipment. Enoxaparin Sodium for Injection Lot SAB06761A was shipped to customers in the months of September and October 2021.

The exposure to higher temperatures may have significantly impacted the recalled product’s (lot SAB06761A) effectiveness and thus there may be reasonable probability of risk for patients with health conditions that the product is intended to treat. Such patients could be at risk for blood clots blocking blood vessels, an artery, or traveling to other tissues or organs causing pain, swelling, stroke, clots to the lung or death as a result of the underlying condition. To date, Sandoz has not received any reports of adverse events or injuries related to this recall.

The product is used for prevention of deep vein thrombosis (DVT) a condition that occurs when a blood clot forms in a deep vein, usually in the legs that can occur after surgeries or in patients with restricted mobility during illness; or prevention of complications associated with heart attacks. The product is packaged in cartons containing ten 0.4 mL syringes, NDC 0781-3246-64. Enoxaparin Sodium Injection was distributed Nationwide in the USA to wholesalers and retailers.

Product Name: Enoxaparin Sodium, Injection, USP 40mg/0.4 mL
NDC Number: 00781-3246-64
Lot Number: SAB06761A
Expiration Date: 04/2023
Date of Manufacture: 05/26/2021

Please note: this recall is specific to only one batch (SAB06761A) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL and does not apply to any other strengths of Sandoz Enoxaparin Sodium Injection, USP or to other lots of the 40 mg/0.4 mL SKU.

Any product returned that is not associated with this recall will be destroyed and no credit issued.

Company name: Sandoz, Inc.
Brand name: Sandoz
Product recalled: Enoxaparin Sodium Injection
Reason of the recall: Exposure to high temperatures may have impacted product effectiveness.
FDA Recall date: December 02, 2021

Check the full recall details on fda.gov

Source: FDA
See Less
102


Mountain Meadow Herbs of Somers, MT is recalling 54 bottles (total 240 capsules per bottle) of Mountain Meadow Herbs brand Candida Flush, Lot# 0120011Q. Some bottles from this Lot have become pressurized over time in storage. When opened, the product may forcefully expel air as well as... See More portions of capsules and powder. This may result in customers sustaining injuries to their hands and eyes, which may require medical attention.

Product was distributed to retailers in IN, MN, MT, NY, TN and in Ontario of Canada.
Product was sold directly to consumers in IN, KY, MN, MO, MT, NE, OH, PA, VA, and WI. The affected Candida Flush has the UPC 8 13086 01593 2, Lot #012001l Q, Exp 12/22.

No illnesses or serious injuries have been reported to date. The recall was the result of an internal investigation stemming from a customer complaint which revealed that the finished products were becoming pressurized over time.

This recall is being made with the knowledge of the U.S. Food and Drug Administration. If you have any of these products, please dispose of them immediately.

Company name: Mountain Meadow Herbs
Brand name: Mountain Meadow Herbs
Product recalled: Candida Flush
Reason of the recall: Due to exploding bottle risk
FDA Recall date: November 17, 2021

Check the full recall details on fda.gov

Source: FDA
See Less
2


FOR IMMEDIATE RELEASE – December 4, 2021 – Colchester, VT, Edge Pharma, LLC is voluntarily recalling all lots of all drugs compounded at Edge Pharma, LLC to the consumer level. All products are being recalled due to process issues that could lead to a lack of sterility... See More assurance for products intended to be sterile and could impact the safety and quality of non-sterile products.

Risk Statement: Administration of a drug product intended to be sterile, that is not sterile, could result in site specific infections as well as serious systemic infections which may be life- threatening. To date, Edge Pharma, LLC has not received and is not aware of any adverse events related to this recall. The products are used for a variety of indications and are packaged in Containers, IV bags, Syringes, Drop containers, Vials, Bottles, and Jars. The affected lots and expiration dates are included in the link listed below. The names and concentration of the drugs are listed in the link below.

The recall encompasses all compounded sterile and nonsterile drug products, within expiry, that were dispensed from Edge Pharma, LLC. The products subject to this recall were distributed nationwide and directly to customers and/or medical facilities. The products can be identified by the label containing the Edge Pharma, LLC name and logo. Edge Pharma, LLC is notifying its customers by email, Media and FDA alerts, and direct outreach.

Consumers and institutions that have Edge Pharma, LLC products should stop using the products immediately and may either return or discard the recalled lots. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Company name: Edge Pharma, LLC
Brand name: Edge Pharma, LLC
Product recalled: All drugs compounded at Edge Pharma, LLC
Process issues that could lead to a lack of sterility assurance for products intended to be sterile and could impact the safety and quality of non-sterile products
FDA Recall date: December 07, 2021

Check the full recall details on fda.gov

Source: FDA
See Less
101


I shipped Priority Express on Nov 15 to Essex Junction, VT and after two days it is still showing arrived at Teterboro Distribution Center, Industrial Avenue, Teterboro, NJ, USA on 11/15/2021 at 9:22pm. It should be delivered by Nov 16 at VT See Less
5.4K


Sagent Pharmaceuticals, Inc. on November 19 announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container closure integrity, found in reserve sample vials may result in a non-sterile product.

Risk Statement: Intravenous administration of a product intended... See More to be sterile that is not sterile could result in serious systemic infections which may be life-threatening. 

To date, Sagent has not received reports of any product complaints or adverse events associated with this issue. Levetiracetam Injection, USP 500 mg per 5 mL, is used in the treatment of certain types of seizures and is packaged in a 5mL single-does vial. The Levetiracetam Injection, USP, label and affected lot numbers with Expiration Dates and NDC number can be found in the table below. 

Product: Levetiracetam Injection, USP / Lot Number: B0G85VB /Expiration Date: Jun-2022 / NDC Number: 25021-780-05 / Distribution Dates: May 2021 - August 2021.

Product: Levetiracetam Injection, USP / Lot Number: B0K88VA /Expiration Date: Sep-2022 / NDC Number: 25021-780-05 / Distribution Dates: March 2021 - November 2021.

Product: Levetiracetam Injection, USP / Lot Number: B0K89VA /Expiration Date: Sep-2022 / NDC Number: 25021-780-05 / Distribution Dates: August 2021 - November 2021.

Product: Levetiracetam Injection, USP / Lot Number: B1G194A /Expiration Date: Jun-2023 / NDC Number: 25021-780-05 / Distribution Dates: October 2021.

The product was distributed Nationwide from March to November  2021.

Company name: Sagent Pharmaceuticals, Inc.
Brand name: Sagent
Product recalled: Levetiracetam Injection
Reason of the recall: Lack of sterility assurance
FDA Recall date: November 22, 2021

Check the full recall details on fda.gov

Source: FDA
See Less
101